Investigation on the possibility of dynamic COVID-Zero strategy in China: a population-based transmission model analysis and economic evaluation

Author:

Wang Xuechun,Pei ShaojunORCID,Wang Lianhao,La Bin,Zhao Mingchen,Zhang Xiangyu,Jia Zhongwei

Abstract

ObjectiveTo explore the feasible and cost-effective intervention strategies to achieve the goal of dynamic COVID-Zero in China.DesignA Susceptible–Exposed–Infectious–Recovered model combined economic evaluation was used to generate the number of infections, the time for dynamic COVID-Zero and calculate cost-effectiveness under different intervention strategies. The model simulated the 1 year spread of COVID-19 in mainland China after 100 initial infections were imported.InterventionsAccording to close contact tracing degree from 80% to 100%, close contact tracing time from 2 days to 1 day, isolation time from 14 days to 7 days, scope of nucleic acid testing (NAT) from 10% to 100% and NAT frequency from weekly to every day, 720 scenarios were simulated.Outcome measureCumulative number of infections (CI), social COVID-Zero duration (SCD), total cost (TC) and incremental cost-effectiveness ratio.Results205 of 720 scenarios could achieve the total COVID-Zero since the first case was reported. The fastest and most cost-effective strategy was Scenario 680, in which all close contacts were traced within 1 day, the isolation time was 14 days and 10% of the national population was randomly checked for NAT every day. In Scenario 680, the CI was 280 (100 initial infections) and the SCD was 13 days. The TC was ¥4126 hundred million and the cost of reducing one infection was ¥47 470. However, when the close contact tracing time was 2 days and the degree of close contact tracing was 80%–90%, the SCD would double to 24–101 days and the TCs increased by ¥16 505 to 37 134 hundred million compared with Scenario 680.ConclusionsIf all close contact was controlled within 1 day, the rapid social COVID-Zero can be achieved effectively and cost-effectively. Therefore, the future prevention and control of emerging respiratory infectious diseases can focus on enhancing the ability of close contact tracing.

Publisher

BMJ

Subject

General Medicine

Reference42 articles.

1. He L . The US state of California is implementing a pandemic policy in response to the Coronavirus outbreak [China News]. 2022. Available: https://news.cctv.com/2022/02/18/ARTIk6a9zcR9dBZgU7xLbdle220218.shtml

2. Toy S , Kamp J . The US CDC is relaxing guidelines on face masks as the COVID-19 outbreak eases [The Wall Street Journal]. 2022. Available: https://cn.wsj.com/articles/%E7%BE%8E%E5%9B%BDcdc%E6%94%BE%E6%9D%BE%E5%8F%A3%E7%BD%A9%E4%BD%A9%E6%88%B4%E6%8C%87%E5%BC%95-%E5%9B%A0%E6%96%B0%E5%86%A0%E7%96%AB%E6%83%85%E7%BC%93%E8%A7%A3-11645844489

3. “Economic considerations behind whether COVID-19 policy should be "zero-case" or "live with the virus” [BBC NEWS]. 2021. Available: https://www.bbc.com/zhongwen/simp/world-57983677

4. Yao H , Wang J , Liu W . Lockdown policies, economic support, and mental health: evidence from the COVID-19 pandemic in United States. Front Public Health 2022;10:857444. doi:10.3389/fpubh.2022.857444

5. Sarkar K , Khajanchi S , Nieto JJ . Modeling and forecasting the COVID-19 pandemic in India. Chaos Solitons Fractals 2020;139:110049. doi:10.1016/j.chaos.2020.110049

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3